May 14, 2024, 10:05
Amalya Sargsyan: Novel weapons in LCSM to be presented at ASCO
Amalya Sargsyan, Medical Oncologist at the Yeolyan Oncology and Hematology Center, shared a post on X:
“Novel weapons in LCSM to be presented at ASCO.
Sunvozertinib in EGFR exon20 NSCLC with 61%ORR and 88%DCR
Zongertinib for HER2 mutant NSCLC with 45%ORR & 91%DCR
Taletrecrinib in ROS1+ NSCLC, ORR 92% & DCR of 89.5%
SGNB6A-001 for advanced solid tumors 33%ORR in NSCLC”
Source: Amalya Sargsyan/X
OncoDaily
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12